Kimberly Harris Archives
New treatment for Crohn’s disease
Mar. 22, 2016—A new biological therapy, ustekinumab, improves markers of disease activity in patients with severe Crohn’s disease.
Mar. 22, 2016—A new biological therapy, ustekinumab, improves markers of disease activity in patients with severe Crohn’s disease.
©
Vanderbilt University Medical Center · All rights reserved.
Vanderbilt University Medical Center is committed to principles of equal opportunity and affirmative action.
Vanderbilt®, Vanderbilt University Medical Center®, V Oak Leaf Design®, Monroe Carell Jr. Children’s Hospital at Vanderbilt® and Vanderbilt Health® are trademarks of The Vanderbilt University.